Here, we demonstrated that HDAC pathway CNV was significantly associated with chemokines in SARC, BRCA, STAD, and UVM, suggesting that combination of HDACi and immunotherapy may potentially be of significance in the cancer treatment. The gene discussed is HDAC9; the disease is cancer.